| AZN |
AstraZeneca
|
FTSE 100
| 2.38 |
£158.91B
| 10,144.00 | -1.01% |
| GSK |
GSK
|
FTSE 100
| 4.37 |
£57.05B
| 1,395.00 | 0.04% |
| HLN |
Haleon
|
FTSE 100
| 1.72 |
£34.45B
| 377.60 | -1.51% |
| SN. |
Smith & Nephew
|
FTSE 100
| 2.52 |
£9.6B
| 1,101.00 | 0.41% |
| CTEC |
ConvaTec Group
|
FTSE 100
| 1.63 |
£5.95B
| 288.80 | -0.48% |
| HIK |
Hikma Pharmaceuticals
|
FTSE 100
| 2.85 |
£4.52B
| 1,999.00 | -1.82% |
| HCM |
Hutchmed China
|
AIM
| |
£1.93B
| 221.00 | 4.80% |
| GNS |
Genus
|
FTSE 250
| 1.66 |
£1.27B
| 1,966.00 | 2.18% |
| INDV |
Indivior
|
FTSE 250
| |
£1.26B
| 1,008.00 | -3.10% |
| SPI |
Spire Healthcare Group
|
FTSE 250
| 1.06 |
£873.99M
| 224.00 | 3.23% |
| UPR |
Uniphar
|
AIM
| 0.01 |
£824.25M
| 315.00 | 0.90% |
| AMS |
Advanced Medical Solutions Group
|
AIM
| 1.21 |
£464.84M
| 214.00 | 3.10% |
| AGY |
Allergy Therapeutics
|
AIM
| |
£367.02M
| 7.30 | -2.50% |
| OXB |
Oxford BioMedica
|
FTSE Small Cap
| |
£330.59M
| 320.00 | 2.73% |
| PRTC |
Puretech Health
|
FTSE Small Cap
| |
£298.8M
| 128.40 | 3.22% |
| NIOX |
Niox Group
|
AIM
| 1.93 |
£270.49M
| 65.60 | |
| FARN |
Faron Pharmaceuticals OY
|
AIM
| |
£215.51M
| 185.00 | 1.10% |
| ANCR |
Animalcare Group
|
AIM
| 1.82 |
£196.62M
| 292.00 | -2.60% |
| TSTL |
Tristel
|
AIM
| 3.32 |
£194.43M
| 400.00 | 1.60% |
| BMK |
Benchmark Holdings
|
AIM
| |
£178.18M
| 24.20 | 1.50% |
| MXCT |
Maxcyte Inc
|
AIM
| |
£161.75M
| 147.69 | -1.20% |
| 4BB |
4basebio
|
AIM
| |
£152.45M
| 992.00 | -0.40% |
| BVXP |
Bioventix
|
AIM
| 5.85 |
£138.46M
| 2,750.00 | -2.20% |
| EKF |
EKF Diagnostics Holdings
|
AIM
| |
£119.01M
| 26.75 | 1.00% |
| AVCT |
Avacta Group
|
AIM
| |
£118.55M
| 30.50 | -7.00% |
| SCLP |
Scancell Holdings
|
AIM
| |
£100.16M
| 9.25 | -1.10% |
| SDI |
SDI Group
|
AIM
| |
£96.19M
| 89.50 | -1.50% |
| DXRX |
Diaceutics
|
AIM
| |
£95.52M
| 118.50 | -0.50% |
| ANP |
Anpario
|
AIM
| 2.71 |
£86.89M
| 415.00 | -0.90% |
| HVO |
Hvivo
|
AIM
| 1.72 |
£79.09M
| 11.65 | -5.10% |
| ANIC |
Agronomics
|
AIM
| |
£71.67M
| 7.02 | -0.60% |
| OBI |
Ondine Biomedical Inc
|
AIM
| |
£63.19M
| 14.25 | 2.60% |
| CREO |
Creo Medical Group
|
AIM
| |
£54.33M
| 13.75 | -0.80% |
| SPEC |
Inspecs Group
|
AIM
| |
£49.82M
| 49.38 | -0.30% |
| SBTX |
SkinBioTherapeutics
|
AIM
| |
£42.05M
| 16.63 | -14.90% |
| EAH |
Eco Animal Health Group
|
AIM
| |
£42.01M
| 60.50 | -4.30% |
| KMK |
Kromek Group
|
AIM
| |
£39.95M
| 6.05 | 8.70% |
| NCYT |
Novacyt SA
|
AIM
| |
£28.48M
| 42.30 | 4.20% |
| STX |
Shield Therapeutics
|
AIM
| |
£27.08M
| 2.85 | -7.90% |
| ABDX |
Abingdon Health
|
AIM
| |
£26.32M
| 7.00 | 2.60% |
| FUM |
Futura Medical
|
AIM
| |
£25.61M
| 8.43 | 14.60% |
| AGL |
Angle
|
AIM
| |
£24.11M
| 7.50 | -0.70% |
| POLB |
Poolbeg Pharma
|
AIM
| |
£22.31M
| 3.20 | -2.10% |
| TRX |
Tissue Regenix Group
|
AIM
| |
£22.08M
| 29.05 | -1.50% |
| IHC |
Inspiration Healthcare Group
|
AIM
| |
£21.07M
| 23.50 | 0.60% |
| EDEN |
Eden Research
|
AIM
| |
£20M
| 3.75 | -2.40% |
| SAR |
Sareum Holdings
|
AIM
| |
£19.49M
| 15.00 | -5.60% |
| POLX |
Polarean Imaging
|
AIM
| |
£16.9M
| 1.40 | -3.20% |
| AREC |
Arecor Therapeutics
|
AIM
| |
£16.42M
| 43.50 | -1.30% |
| COG |
Cambridge Cognition Holdings
|
AIM
| |
£14.02M
| 33.50 | -0.40% |
| OPTI |
OptiBiotix Health
|
AIM
| |
£11.75M
| 11.25 | -3.30% |
| IMM |
ImmuPharma
|
AIM
| |
£11.32M
| 2.52 | -3.00% |
| IXI |
Ixico
|
AIM
| |
£9.5M
| 10.25 | -1.50% |
| PRM |
Proteome Sciences
|
AIM
| |
£9M
| 3.05 | 8.00% |
| GDR |
Genedrive
|
AIM
| |
£8.75M
| 1.42 | -1.60% |
| RUA |
RUA Life Sciences
|
AIM
| |
£8.3M
| 12.63 | -6.90% |
| CEL |
Celadon Pharmaceuticals
|
AIM
| |
£8.26M
| 11.50 | |
| OBD |
Oxford BioDynamics
|
AIM
| |
£7.83M
| 0.37 | -4.00% |
| FAB |
Fusion Antibodies
|
AIM
| |
£7.16M
| 6.36 | 25.90% |
| SUN |
Surgical Innovations Group
|
AIM
| |
£6.53M
| 0.65 | -2.30% |
| GENI |
Genincode
|
AIM
| |
£6.45M
| 2.25 | 1.40% |
| MHC |
MyHealthChecked
|
AIM
| |
£5.59M
| 10.75 | 5.30% |
| BELL |
Belluscura
|
AIM
| |
£2.91M
| 0.72 | -1.10% |
| VRCI |
Verici Dx
|
AIM
| |
£2.73M
| 1.23 | -4.80% |
| VAL |
ValiRx
|
AIM
| |
£2.25M
| 0.60 | -2.20% |
| PYC |
Physiomics
|
AIM
| |
£1.49M
| 0.47 | -3.80% |
| GUN |
Gunsynd
|
AIM
| |
£1.23M
| 0.13 | 9.50% |
| TRLS |
Trellus Health
|
AIM
| |
£1.05M
| 0.65 | 7.30% |
| TLY |
Totally
|
AIM
| |
–
| 0.24 | -1.90% |